Natural Inhibitors and Lipids in Patients with Sickle Cell Disease

Area of Science:

• Hematology
• Vascular Biology
• Coagulation Disorders

Background:

• Microvascular occlusion in sickle cell disease (SCD) is complex.
• Disordered coagulation is a potential factor in vaso-occlusive crisis (VOC) pathogenesis.

Purpose of the Study:

• To evaluate Protein C (PC), Protein S (PS), and AT-III levels in SCD patients.
• To investigate if these levels change during normal versus crisis periods.

Main Methods:

• Assessed PC, PS, and AT-III levels in 18 SCD patients.
• Compared levels during non-crisis and crisis periods to controls.
• Analyzed lipid profiles, hepatic, and renal functions.

Main Results:

• SCD patients exhibited lower mean PC, PS, and AT-III levels than controls (p<0.001).
• No significant difference in PC, PS, and AT-III levels was observed between non-crisis and crisis periods.
• Patients showed lower cholesterol and higher triglycerides during non-crisis periods compared to controls.

Conclusions:

• Deficiencies in PC, PS, and AT-III are confirmed in SCD patients.
• These deficiencies do not appear to influence the occurrence or severity of VOC.
• Abnormal lipid patterns may contribute to VOC predisposition in SCD.